Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
- Thursday, November 19, 2020, 7:04
- Finance
- Add a comment
BURGDORF, Switzerland and INDIANAPOLIS, Nov. 19, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Ypsomed (SWX: YPSN) announced today a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly’s connected diabetes solutions. Under the…
About the Author
adminasapcorp has written 42559 stories on this site.